tag:blogger.com,1999:blog-8964719845369935777.post1882304366433948156..comments2024-03-27T21:23:40.339-04:00Comments on Chemjobber: Lilly's John Lechleiter and PhRMA's John Castellani on pharma layoffs: no good answers for ScienceCareers' Beryl BenderlyChemjobberhttp://www.blogger.com/profile/15932113680515602275noreply@blogger.comBlogger5125tag:blogger.com,1999:blog-8964719845369935777.post-85913394664802632642014-02-26T21:07:54.000-05:002014-02-26T21:07:54.000-05:00EliLily saying they employ foreign graduates is no...EliLily saying they employ foreign graduates is not true either. I have people of foreign origin, who were PhD trained within the US or Europe (UK/France/Germany), pursued post-doctoral training in Europe and US and yet when they apply for positions, they often encounter a statement saying EliLily will not be able to obtain sponsor visa. <br /><br />So, they dont consider foreign candidates, they say there aren't US candidates...who are they actually employing? If companies do not invest in employing US/global candidates, this is drastically impact science of the future and drug development and an entire working generation will be lost. <br /><br />Concentrating on profits should NOT always be the driving force especially at hard times. Think big and think of the future.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-8964719845369935777.post-61861232227165233282014-01-28T14:54:48.335-05:002014-01-28T14:54:48.335-05:00There is plenty of "talent" when it come...There is plenty of "talent" when it comes to medical doctors, pharmacists, dentists, optometrists, etc. People go into those field because there are jobs, stability, and because those jobs actually pay.<br /><br />Props to Ms. Benderly for asking the hard question.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-8964719845369935777.post-9381704838190205722014-01-27T20:30:55.443-05:002014-01-27T20:30:55.443-05:00The fact that this took place in Washington leads ...The fact that this took place in Washington leads me to believe that the pharma companies and their trade association were primarily focused on influencing the Washington media and (especially) influencing those involved in science policy, be they think tanks, government personnel or members of Congress and their staffers. One wonders, what does pharma want in return for their 'feel good' STEM education initiative? Better tax breaks? Immigration reform that benefits them? Less scrutiny/criticism from the media or Congress? <br /><br />Kudos to Beryl Benderly for asking a tough question. I bet it was one that Lechleiter and Castellani weren't expecting. Hopefully the others in the room took note of her points, and weren't too bowled over with the non-responses from the two men.<br /><br />I see that one of the panelists for this conference is a person from Cubist. Isn't that the company that runs strange ads on the ACS job board?Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-8964719845369935777.post-12841743215156884922014-01-27T12:36:08.385-05:002014-01-27T12:36:08.385-05:00This comment has been removed by the author.Brenthttps://www.blogger.com/profile/01473845062417140897noreply@blogger.comtag:blogger.com,1999:blog-8964719845369935777.post-3030875199393081882014-01-27T12:22:49.836-05:002014-01-27T12:22:49.836-05:00IF USNWR report is looking at projections for STEM...IF USNWR report is looking at projections for STEM fields, what do the salary trends look like? If the salary trends aren't upward, then those stinkin' employment numbers aren't the ones lying here.Hapnoreply@blogger.com